Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases
Authors:
- Frederik A VerburgFVFrederik A Verburg
- Uwe MäderUMUwe Mäder
- Markus LusterMLMarkus Luster
- Christoph ReinersCRChristoph Reiners
- 1 April 2009
- journal article
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 160 (4) , 619-624
Abstract
Objective: Papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC) show considerable differences in disease stage at initial presentation. The aim of this study was to investigate whether there are differences in tumour-specific survival if initial staging is accounted for.Design: Retrospective chart review study.Patients: The study sample comprised 875 PTC and 350 FTC patients (856 females, 369 males, mean age 47.8 years) treated in our hospital from 1978 to 2002. All patients received total thyroidectomy with subsequent I-131 ablation except for those patients with an isolated papillary microcarcinoma.Methods: Kaplan–Meier analyses and Cox-regression analyses were performed to assess the influence of histology on thyroid cancer-specific survival.Results: FTC patients were on average older, more likely to be male, presented with a larger tumour and more frequently had multifocal carcinoma and distant metastases than PTC patients, whereas they presented less frequently with extrathyroidal invasion or lymph node metastases. Twenty-year tumour-specific survival in PTC was 90.6% and in FTC 73.7% (PPPP=0.001) and the presence of extrathyroidal invasion (P=0.007), but not histology (P=0.26), were independent determinant variables for tumour-specific survival.Conclusion: There is no difference in tumour-specific survival between PTC and FTC when accounting for the presence of metastases, age, tumour size and the presence of extrathyroidal invasion.Keywords
This publication has 21 references indexed in Scilit:
- MicroRNA Expression Profiling of Thyroid Tumors: Biological Significance and Diagnostic UtilityThe Journal of Clinical Endocrinology & Metabolism, 2008
- Prognostic factors determining survival in differentiated thyroid cancerJournal of Surgical Oncology, 2007
- Microarray Analysis of Thyroid Nodule Fine-Needle Aspirates Accurately Classifies Benign and Malignant LesionsThe Journal of Molecular Diagnostics, 2006
- European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epitheliumEuropean Journal of Endocrinology, 2006
- The prognostic value of primary tumor size in papillary and follicular thyroid carcinomaCancer, 2005
- Prognostic Factors Determining Long-Term Survival in Well-Differentiated Thyroid Cancer: An Analysis of Four Hundred Eighty-Four Patients Undergoing Therapy and Aftercare at the Same InstitutionThyroid®, 2003
- Differentiated thyroid carcinoma: Comparison between papillary and follicular carcinoma in a single instituteHead & Neck, 2002
- Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996Cancer, 2000
- Presidential address: Beyond risk groups—A new look at differentiated thyroid cancerSurgery, 1998
- Morbidity and mortality in follicular thyroid cancerThe Journal of Clinical Endocrinology & Metabolism, 1995